Modulation of in vivo immunoglobulin production by endogenous histamine and H1R and H2R agonists and antagonists

Pharmacol Rep. 2010 Sep-Oct;62(5):917-25. doi: 10.1016/s1734-1140(10)70352-2.

Abstract

The present study was designed to delineate the immunomodulatory role of histamine receptors (H1R and H2R) and their antibody generation in a rabbit model. Six groups containing 18 rabbits each received either vehicle (sterile distilled water, 1 ml/kg x b.i.d), histamine (100 μg/kg x b.i.d.), H1R agonist (HTMT, 10 μg/kg x b.i.d.), H2R agonist (amthamine, 10 μg/kg x b.i.d.), H1R antagonist (pheniramine, 10 mg/kg x b.i.d.) or H2R antagonist (ranitidine, 10 mg/kg x b.i.d.). All animals were subsequently immunized with an intravenous injection of sheep red blood cells (SRBC). Estimations of total serum immunoglobulins (Igs), immunoglobulin M (IgM) and immunoglobulin G (IgG) were performed by ELISA and hemagglutination assay (HA) at days 0 (pre-immunization), 7, 14, 21, 28 and 58 (post-immunization). Both the ELISA and the HA showed similar production of Igs, IgM and IgG but the results were found comparatively more significant by ELISA as opposed to HA. Results showed that histamine could influence a detectable antibody response to SRBC early (i.e., at day 7), which lasted until day 58. Immunomodulatory processes showed suppression of an Ig generation in the H1R-antagonist group with enhancement in the H2R-antagonist group. The H1R-agonist group showed an increased Ig production in comparison to the H2R-agonist group. The IgM production was inhibited in the H1R-antagonist group as compared to the H2R-antagonist group, and it was also suppressed in H1R-agonist group as compared to H2R-agonist group. IgG production was inhibited in the H1R-antagonist group as opposed to the H2R-antagonist group. In contrast, the H1R-agonist group increased IgG production as compared to the H2R-agonist group. All the results were found to be statistically significant (p < 0.05 or p < 0.01). In conclusion, histamine and its receptor (H1R and H2R) agonists enhance antibody production by triggering the histamine receptors (H1R and H2R), and both the H1R antagonist and the H2R antagonist positively or negatively regulate the antibody production. The findings of this study may have clinical significance.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibody Formation / drug effects
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hemagglutination Tests
  • Histamine / administration & dosage
  • Histamine / analogs & derivatives
  • Histamine / pharmacology
  • Histamine / physiology*
  • Histamine Agonists / administration & dosage
  • Histamine Agonists / pharmacology*
  • Histamine H1 Antagonists / administration & dosage
  • Histamine H1 Antagonists / pharmacology*
  • Histamine H2 Antagonists / administration & dosage
  • Histamine H2 Antagonists / pharmacology*
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin G / blood
  • Immunoglobulin M / biosynthesis
  • Immunoglobulin M / blood
  • Immunoglobulins / biosynthesis*
  • Immunoglobulins / blood
  • Immunomodulation
  • Male
  • Pheniramine / administration & dosage
  • Pheniramine / pharmacology
  • Rabbits
  • Ranitidine / administration & dosage
  • Ranitidine / pharmacology
  • Thiazoles / administration & dosage
  • Thiazoles / pharmacology

Substances

  • Histamine Agonists
  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Immunoglobulin G
  • Immunoglobulin M
  • Immunoglobulins
  • Thiazoles
  • histamine trifluoromethyl-toluidide
  • Pheniramine
  • amthamine
  • Histamine
  • Ranitidine